相关实验视频

Updated: Sep 14, 2025

Induction of Drug-Induced, Autoimmune Hepatitis in BALB/c Mice for the Study of Its Pathogenic Mechanisms

Induction of Drug-Induced, Autoimmune Hepatitis in BALB/c Mice for the Study of Its Pathogenic Mechanisms

Published on: May 29, 2020

与阿扎西奥普林相比,mycophenolate mofetil在自身免疫性肝炎中的有效性和安全性:一个元分析

Shahryar Khan¹, Mashal Alam Khan², Aamer Ahmad²

¹Department of Medicine, University of Kansas Medical Center, Kansas City, KS, USA.

Gastroenterology research

|July 21, 2025

概括

在自身免疫性肝炎 (AIH) 中,mycophenolate mofetil (MMF) 的生化缓解率高于azathioprine (AZA). 对于对AZA无反应或不耐受的患者来说,MMF是一种有希望的替代品,尽管需要长期数据.

科学领域:

肝病学和免疫学肝病学和免疫学
临床药理学临床药理学

背景情况:

自身免疫性肝炎 (AIH) 治疗通常涉及皮质类固醇和阿扎西奥普林 (AZA).
患者对标准AIH疗法的不耐受或不响应需要选择其他治疗方案.
菌酸莫菲蒂尔 (MMF) 正在被探索为AIH管理的潜在替代品.

研究的目的:

系统地审查和比较MMF与AZA在AIH治疗中的生化疗效.
在AIH患者中评估MMF和AZA的安全性.
评估MMF在AIH患者的有效性,这些患者对AZA不反应或不耐受.

主要方法:

在2024年11月之前对MEDLINE和EMBASE数据库进行系统文献审查.
主要结局包括生化缓解 (BR),MMF在AZA不响应 (AZA-NR) 和AZA不耐受 (AZA-IT) 患者中的疗效,不良事件 (AEs) 和整体存活率.
11项涉及952名参与者的研究的元分析 (57.45%的MMF).

主要成果:

与AZA (53.64%) 相比,MMF表现出明显更高的BR率 (88.57%) 和AZA (53.64%).
货币货币基金显示,与AZA相比,BR率大幅提高 (OR:7.81,95% CI:2.21 - 27.69).
在AZA-NR (61%) 和AZA-IT (61.73%) 患者中,MMF显著提高了疗效;在MMF和AZA之间没有注意到AE或整体存活率的显著差异.

结论:

在AIH中,MMF可以作为AZA的可行的一线替代品,特别是对于对AZA反应不佳或不耐受的患者.
与AZA相比,MMF在AIH患者中表现出更高的生化缓解率.
需要进一步的随机对照试验来研究MMF在AIH中的长期疗效和安全性.

关键词:

这就是AIH.亚萨亚萨是一个人.不良事件是不良事件.生物化学缓解可以缓解.没有容忍的不容忍.货币货币基金组织 (MMF) 是一个MMF.没有响应的不响应.没有接受过治疗的天真.

更多相关视频

Quantification of the Immunosuppressant Tacrolimus on Dried Blood Spots Using LC-MS/MS

Quantification of the Immunosuppressant Tacrolimus on Dried Blood Spots Using LC-MS/MS

Published on: November 8, 2015

The CYP2D6 Animal Model: How to Induce Autoimmune Hepatitis in Mice

The CYP2D6 Animal Model: How to Induce Autoimmune Hepatitis in Mice

Published on: February 3, 2012

相关概念视频

Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents

Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents

Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...

Drugs for Treatment of Ulcerative Colitis in IBD

Drugs for Treatment of Ulcerative Colitis in IBD

Ulcerative colitis is a chronic inflammatory condition primarily affecting the colon and rectum. The primary drugs used in the treatment of ulcerative colitis are aminosalicylates. They exhibit anti-inflammatory and immunosuppressive properties. They modulate inflammatory mediators and inhibit the activity of nuclear factor κB (NF-κB). Aminosalicylates also reduce inflammation by inhibiting prostaglandin and leukotriene production and decreasing neutrophil chemotaxis and superoxide...